You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》匯豐研究下調海吉亞醫療(06078.HK)目標價至70元 評級「買入」
阿思達克 08-01 10:16
匯豐研究發表報告指,海吉亞醫療(06078.HK)收購了長安醫院,預計醫院在2023至25財年將達到超過8億至10億元人民幣的銷售額和1.08億至1.52億人民幣的淨利潤,分別佔2023年總收入及淨利潤的20%和14%,而到2024至25年則分別佔15%和11%,預計收入整合將於2023財年9月或10月開始。 該行認為,長安醫院是優質的收購項目,是次收購價合理,料隨後的整合將促進集團增長,而醫院將成為其主要的收入貢獻,並應在2024和25財年實現20%以上的收入增長,而且盈利仍有進一步增長空間。 該行上調集團2023至25財年的盈利預測3至5%,以反映由收購帶來的貢獻增長高於預期,及料2022至25年的收入和盈利複合年增長率將穩定在約30%。不過,該行將集團目標價由78元下調至70元,維持「買入」評級。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account